Concepedia

Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy

DB Smith, ES Newlands, OW Spruyt, RHJ Begent, GJS Rustin, B Mellor, K. D. Bagshawe

British Journal of Cancer · 1990 · 50 citations · 6 references

DOIFull text

Open access

Concepts

References

6

Statistical Methods in Medical Research.

C Wickham, P. Armitage, George Berry · Journal of the Royal Statistical Society Series A (Statistics in Society) · 1988 · 1.4K citations

, , +10

Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism

Wesley D. Miner, Gareth J. Sanger · British Journal of Pharmacology · 1986 · 338 citations · Full text

, , +9

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients

Mark G. Kris, Richard J. Gralla, Leslie B. Tyson et al. · Cancer · 1985 · 196 citations · Full text

, , +15

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

David Cunningham, A. Pople, H.T. Ford et al. · The Lancet · 1987 · 192 citations

, , +9

5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis

B. Costall, A.M. Domeney, R.J. Naylor et al. · Neuropharmacology · 1986 · 188 citations

, , +10